Structural
Aortic Valve Intervention Learning Series
Aortic Stenosis - General Concepts
Episodes
High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
11 min.
Moderate AS With Heart Failure: UNLOAD and Beyond
9 min.
Managing Heart Failure in AS With Multivalve Disease
10 min.
Low Flow - Low Gradient AS and Assessing Myocardial Reserve
15 min.
Recurrent Heart Failure After AVR: Causes and Treatment
8 min.
AS Reclassified According to Valve Function and Cardiac Disease
11 min.
Structural Keynote Lecture: Essentials of Lifetime Management of Aortic Disease in 2023
17 min.
Does Mild PVL Really Matter and What Can Be Done About It?
14 min.
Minimalist TAVR And What It Means for Procedural Optimization in 2023
12 min.
When Do I Really Need a Cardiac Catheterization in Anticipation of TAVR?
13 min.
Where It All Begins: Valve Clinic and the Multidisciplinary Heart Team
8 min.
A Challenging Case of Clinical Valve Thrombosis
3 min.
Defining Valve Thrombosis: Making Sense of Alphabet Soup
5 min.
Clinical Valve Thrombosis: Diagnosis, Management, and Prognosis
14 min.
Prophylactic Antithrombotic Therapy After TAVR
12 min.
I Have a Crystal Ball: What Will the AVR Universe Look Like in 2030?
9 min.
Technical Considerations for Index TAVR in a Younger Patient
15 min.
Position 3: Initial TAVR
16 min.
Position 2: Initial SAVR With Bioprosthetic Valve/Ross
5 min.
Position 1: Initial SAVR With Mechanical Valve
6 min.
Case Presentation: 59-Year-Old Male With Trileaflet Aortic Valve Stenosis
4 min.
Lifetime Management of AS: What Do the Patients Want?
15 min.
Perspective: How I See the Future for TAVR in Younger Patients With Bicuspid AS
7 min.
We Need an RCT, and Here Is How I Would Like to Design It
7 min.
Case Resolution: A Patient <65 Years Old With Severe Symptomatic Bicuspid Aortic Stenosis With Favorable TAVR Anatomy
2 min.
Index SAVR in Young Patients With Bicuspid AS Is Better for Lifetime Management
10 min.
Moderate AS in HFrEF: Time to Treat Is Now
15 min.
Pharmacotherapy to Slow AS Progression and Protect the Heart
9 min.
Moderate AS With Cardiac Damage: The EXPAND TAVR II Trial
8 min.
Moderate AS With Cardiac Damage: The PROGRESS Trial
5 min.
Moderate AS With Heart Failure: TAVR UNLOAD
4 min.
EARLY TAVR
5 min.
EVOLVED: CMR As an Early Marker of Risk
6 min.
Staging of Aortic Stenosis According to Cardiac Dysfunction
7 min.
Imaging-Derived New Phenotypes of AS Severity
7 min.
Updates on ECG-Based Algorithms
5 min.
“Access to Care” Issues in Aortic Stenosis Patients
10 min.
UPSTREAM Aortic Stenosis Management: Conceptual Framework
6 min.
Discordant Echocardiographic and Invasive Hemodynamics in Aortic Stenosis: When Does It Matter?
16 min.
TAVR vs SAVR in Low Gradient AS: Evidence Updates
18 min.
The Case For TAVR in Severe Aortic Stenosis With Small Aortic Annulus
7 min.
SAVR in Severe Aortic Stenosis With Small Aortic Annulus: What Are the Options?
11 min.
Diagnosing Low Gradient Aortic Stenosis: Time to Get It Right
16 min.
Multi-Valve and Concomitant Cardiovascular Disease: Gaps in the Guidelines
17 min.
Keynote: Structural Transcatheter Innovation from China: Highlights of New Valve Therapies Which Will Impact Clinical Practice
20 min.
Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?
8 min.
A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis : How Will Emerging Evidence Help Us?
3 min.
A 70 Year-old Low-risk Woman With Asymptomatic Severe Aortic Stenosis: What Do the Guidelines Say?
4 min.
Patient Prosthesis Mismatch After TAVR – Does Valve Selection Matter in the Small Annulus?
8 min.
Management of Concomitant Coronary Disease in AVR-Eligible Patients – COMPLEAT or NOT?
9 min.
Cerebral Embolic Protection: Why, When, and Who?
7 min.
Expanding TAVR to Moderate Aortic Stenosis: The Next Frontier?
7 min.
Optimal Anti-Thrombotic Therapy After TAVR – Updates and Controversies
10 min.
The Importance of Pre-emptive TAVR in the Future Management of Aortic Stenosis
13 min.
PENDING - CT-Guided ADR in a Calcium-Free LAD CTO Segment in a Post-TAVI/Post-CABG Patient
6 min.